CMS Ends Reimbursement for TENS Treatment

CMS announced that it will no longer cover most uses of transcutaneous electrical nerve stimulation for chronic low back pain, according to a MedPage Today report.

In a memo released Friday and effectively immediately, CMS officials wrote that reimbursement for TENS for low back pain will be available only when patients are participating in a randomized, controlled trial to gauge the clinical effectiveness of the treatment.

"TENS is not reasonable and necessary for the treatment of [chronic low back pain]," the memo said. "Long-standing use of a medical treatment is unfortunately no guarantee that it is in fact clinically appropriate or necessary."

Medicare previously paid for FDA-approved TENS equipment and supplies when prescribed by a physician for chronic pain and reimbursed physicians and physical therapists for evaluating patients' suitability for the treatment.

Related Articles on Pain Management:

Post-Operative Pain Drug Yields Positive Trial Results
Mallinckrodt and Zogenix to Collaborate on Migraine Treatment
50 Pain Management Physician Medical Directors

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.